Reconstitution of T cell subset repertoire diversity following multiple antigen-mismatched bone marrow transplantation.
Friedman
Thea M
TM
Azhipa
Olga
O
Zilberberg
Jenny
J
Tkachuk
Yevgeny
Y
Hsu
Jack W
JW
Rowley
Scott D
SD
Goldberg
Stuart L
SL
Korngold
Robert
R
Pecora
Andrew L
AL
Preti
Robert A
RA
D000328:Adult; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D001549:Benzamides; D001752:Blast Crisis / Q000276:immunology / Q000601:surgery*; D016026:Bone Marrow Transplantation; D019070:Cell Lineage; D003131:Combined Modality Therapy; D005260:Female; D015329:Gene Rearrangement, T-Lymphocyte; D006086:Graft vs Host Disease / Q000517:prevention & control; D006680:HLA Antigens / Q000032:analysis*; D006648:Histocompatibility; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D018655:Lymphocyte Count; D008212:Lymphocyte Depletion; D008297:Male; D009190:Myelodysplastic Syndromes / Q000276:immunology / Q000601:surgery*; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011817:Rabbits; D012074:Remission Induction; D016176:T-Lymphocyte Subsets / Q000166:cytology / Q000637:transplantation*; D014019:Tissue Donors; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous / Q000276:immunology*; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D001549:Benzamides; D006680:HLA Antigens; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate